Assistive Reproductive Technology Market
- 2026 年市場規模
- USD 35,700 Mn
- 2033 年預估規模
- USD 51,200 Mn
- 年複合成長率 CAGR
- 7.8%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Assistive Reproductive Technology Market, By Product Type (Consumables and Instruments), By Technology (In-vitro fertilization (IVF) (IVF with Intracytoplasmic Sperm Injection (ICSI) and IVF without Intracytoplasmic Sperm Injection (ICSI)), Artificial Insemination-Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), and Others), By Procedures (Fresh Donor, Frozen Donor, Fresh Nondonor, Embryo/Egg Banking, and Others), By End User (Fertility Clinics, IVF Center, and Hospital), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Assistive reproductive technology (ART) is an infertility treatment procedure. In this procedure, the sperm and eggs are taken out of the body and oocyte fertilization is done under laboratory environment. The fertilization process carried outside the body is known as In vitro fertilization (IVF). There are mainly two type of IVF procedures such IVF with Intracytoplasmic Sperm Injection (ICSI) and IVF without Intracytoplasmic Sperm Injection (ICSI).
Market Dynamics
Increase in infertility rates over the past years has supported growth of global assistive reproductive technologies market growth. For instance, according to the European society of Human Reproduction and Embryology (ESHRE) in 2018, more than 8 million babies, were born from IVF procedure. This rising number of IVF procedures is expected to boost the global assistive reproductive technology market growth.
Rising prevalence of infertility cases has led to an increase in demand for ART treatment techniques. Furthermore, higher rate of successful pregnancies and births resulting from ART cycles using fresh nondonor eggs or embryos is expected to facilitate the market growth. For instance, in 2016, as per IVF birth rate statistics, around 6.5 million babies were born using in-vitro fertilization (IVF). Moreover, according to the Centers for Disease Control and Prevention (CDC), around 1.6 percent of babies born in the United States each year are conceived through assisted reproductive technology (ART).
ART cycles, are carried out using various procedures such as fresh donor, frozen donor, fresh nondonor, frozen nondonor and embryo/egg banking. The choice of procedures also affects growth of the assistive reproductive technology market, depending upon the type of technology procedures are also chosen. In 2015, according to Centers for Disease Control and Prevention (CDC) 26% fresh nondonor and 42% frozen nondonor procedures were performed in the U.S. These factors are expected to propel the global assistive reproductive technology market growth.
Restraints of the Global Assistive Reproductive Technology Market
One of the major restraints of this market is the issue of legal parental rights, and few concern of people such as, whose names will be there on birth certificate and who will have parental responsibility. Such factors may refrain parents to make use of assistive reproductive technologies.
Key features of the study
• This report provides in-depth analysis of the global assistive reproductive technology market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global assistive reproductive technology market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Cooper Surgical Inc., Hamilton Thorne, Inc., FUJIFILM Irvine Scientific, Inc., Merck KGaA, Nidacon International AB, Vitrolife AB, EMD Serono, Inc., INVO Bioscience, IVFtech ApS, Gonagen Medikal, Cook Medical Llc., and CellCura ASA
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global assistive reproductive technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the assistive reproductive technology market.
Market Segmentation
• By Product Type
o Consumables
o Instruments
• By Technology
o In-vitro fertilization (IVF)
IVF with Intracytoplasmic Sperm Injection (ICSI)
IVF without Intracytoplasmic Sperm Injection (ICSI)
o Artificial Insemination-Intrauterine Insemination (AI-IUI)
o Frozen Embryo Replacement (FER)
o Others
• By Procedures
o Fresh Donor
o Frozen Donor
o Fresh Nondonor
o Embryo/Egg Banking
o Others
• By End User
o Fertility Clinics
o IVF Center
o Hospital
• By Region
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Assistive Reproductive Technology Market Key Players
o Cooper Surgical Inc.
o Hamilton Thorne, Inc.
o FUJIFILM Irvine Scientific, Inc.
o Merck KGaA
o Nidacon International AB
o Vitrolife AB
o EMD Serono, Inc.
o INVO Bioscience
o IVFtech ApS
o Gonagen Medikal
o Cook Medical LLC.
o CellCura ASA.
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Product Type
Market Snippet, By Technology
Market Snippet, By Procedure
Market Snippet, By End User
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Novel Product Launch/Approval
o Acquisitions and Partnerships
o Technological Advancement
o Regulatory Scenario
o Reimbursement Scenario
o Product Recalls
o PEST Analysis
o PORTER’s Analysis
o Epidemiology
4. Global Assistive Reproductive Technology Market, By Product Type, 2026 – 2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026–2033
Segment Trends
o Consumables
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Segment Trends
o Instruments
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Segment Trends
5. Global Assistive Reproductive Technology Market, By Technology, 2026 – 2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026–2033
Segment Trends
o In-vitro fertilization (IVF)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o IVF with Intracytoplasmic Sperm Injection (ICSI)
o IVF without Intracytoplasmic Sperm Injection (ICSI)
o Artificial Insemination-Intrauterine Insemination (AI-IUI)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Frozen Embryo Replacement (FER)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
6. Global Assistive Reproductive Technology Market, By Procedures, 2026 – 2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026–2033
Segment Trends
o Fresh Donor
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Frozen Donor
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Fresh Nondonor
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Embryo/Egg Banking
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
7. Global Assistive Reproductive Technology Market, By End User, 2026 – 2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026–2033
Segment Trends
o Fertility Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o IVF Center
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Hospital
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
8. Global Assistive Reproductive Technology Market, By Region, 2026 – 2033 (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2026–2033
o North America
Market Size and Forecast, By Product Type, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Technology, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Procedure, 2026 – 2033 (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Region, 2026 – 2033 (USD Mn)
o U.S.
o Canada
o Europe
Market Size and Forecast, By Product Type, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Technology, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Procedure, 2026 – 2033 (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Region, 2026 – 2033 (USD Mn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Product Type, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Technology, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Procedure, 2026 – 2033 (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Region, 2026 – 2033 (USD Mn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
Market Size and Forecast, By Product Type, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Technology, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Procedure, 2026 – 2033 (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Region, 2026 – 2033 (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
Market Size and Forecast, By Product Type, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Technology, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Procedure, 2026 – 2033 (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Region, 2026 – 2033 (USD Mn)
o Central Africa
o South Africa
o North Africa
o Middle East
Market Size and Forecast, By Product Type, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Technology, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Procedure, 2026 – 2033 (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033 (USD Mn)
Market Size and Forecast, By Region, 2026 – 2033 (USD Mn)
o GCC
o Israel
o Rest of Middle East
9. Competitive Landscape
o Heat Map Analysis
o Company Profiles
Cooper Surgical Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Hamilton Thorne, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
FUJIFILM Irvine Scientific, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Nidacon International AB
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Vitrolife AB
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
EMD Serono, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
INVO Bioscience
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
IVFtech ApS
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Gonagen Medikal
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Cook Medical LLC.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
CellCura ASA
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Merck KGaA
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
10. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們